Methenamine hippurate for recurrent urinary tract infections
暂无分享,去创建一个
[1] R. Pickard,et al. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial , 2022, BMJ.
[2] Alan D. Lopez,et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis , 2022, The Lancet.
[3] J. Anger,et al. Fear and Frustration among Women with Recurrent Urinary Tract Infections: Findings from Patient Focus Groups , 2021, The Journal of urology.
[4] P. Sand,et al. Methenamine hippurate compared with trimethoprim for the prevention of recurrent urinary tract infections: a randomized clinical trial , 2021, International Urogynecology Journal.
[5] T. Hoffmann,et al. Uncomplicated urinary tract infection in women , 2021, BMJ.
[6] A. Scott,et al. Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-analysis , 2021, The British journal of general practice : the journal of the Royal College of General Practitioners.
[7] M. Blanker,et al. Assessment and treatment of recurrent urinary tract infections in women: development of a questionnaire based on a qualitative study of patient expectations in secondary care , 2020, BMC Urology.
[8] R. Chou,et al. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. , 2019, The Journal of urology.
[9] Prevention of recurrent urinary tract infections in women , 2013, Drug and Therapeutics Bulletin.
[10] B. Trautner,et al. Diagnosis and management of recurrent urinary tract infections in non-pregnant women , 2013, BMJ.
[11] J. Craig,et al. Methenamine hippurate for preventing urinary tract infections. , 2002, The Cochrane database of systematic reviews.